ACTIVE HALF-LIFE
2-3 days
CLASSIFICATION
Non-steroidal aromatase inhibitor
DOSAGE
0.5-1 mg over a period of 1 to 3 days
ACNE
No
WATER RETENTION
No
HBR
No
HEPATOTOXICITY
No
AROMATIZATION
No
MANUFACTURER
Hilma Biocare
LAB TEST
See Document
WAREHOUSE
EU Warehouse 3
SUBSTANCE
Letrozole
Introducing Letrozole, a powerful antitumor medication renowned for its role as a non-steroidal selective aromatase inhibitor. Originally designed for breast cancer treatment and post-menopausal therapy in women, Letrozole has also captured the attention of athletes. Its remarkable anti-estrogenic properties make it an ideal choice for enhancing muscle definition and performance. Notably, Letrozole outshines Anastrozole (Arimidex) by being up to five times more effective at reducing negative side effects linked to anabolic steroid use, effectively lowering estrogen levels to protect against elevated estradiol.
Athletes utilizing Letrozole can significantly curb their estrogen levels and effectively prevent aromatization, promoting better outcomes in their training and physique.
Effects:While Letrozole is effective, some users may experience side effects such as skin rashes, nausea, abdominal discomfort, fatigue, dizziness, headaches, elevated low-density cholesterol levels, and increased liver enzymes.
Side Effects:Before starting Letrozole, it is advisable to conduct preliminary blood tests. This proactive measure can lead to a substantial reduction in estradiol levels, ultimately enhancing the effectiveness of your cycle. As an anti-estrogenic agent, Letrozole is often a key component during post-cycle therapy (PCT).
Protection:Letrozole's effectiveness shines during PCT, but it can also be safely stacked with clomiphene or other steroids to maximize results within a cycle.
Stacking: